The evolution of oral immunotherapy for the treatment of peanut allergy

Clinical and Experimental Allergy

Volumn 41, Issue 9, 2011, Pages 1172-1174

  Allen, K J ^a,b,c   O'Hehir, R E ^d,e  

^a MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

^d ALFRED HOSPITAL   (Australia)

^e MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FOOD ALLERGEN; PEANUT ANTIGEN; PLACEBO; UNCLASSIFIED DRUG;

DESENSITIZATION; DISEASE SEVERITY; DRUG DOSE INCREASE; EDITORIAL; HUMAN; IMMUNOLOGICAL TOLERANCE; MAXIMUM TOLERATED DOSE; ORAL IMMUNOTHERAPY; PATIENT COUNSELING; PEANUT; PEANUT ALLERGY; PRIORITY JOURNAL; REMISSION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ARACHIS HYPOGAEA; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HUMANS; MALE; PEANUT HYPERSENSITIVITY;

EID: 80051729420     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2011.03737.x     Document Type: Editorial

References (8)

1. Sicherer SH, Munoz-Furlong A, Godbold JH, Sampson HA. US prevalence of self-reported peanut, tree nut, and sesame allergy: 11-year follow-up. J Allergy Clin Immunol 2010; 125:1322-6.
2. Poulos LM, Waters AM, Correll PK, Loblay RH, Marks GB. Trends in hospitalizations for anaphylaxis, angioedema, and urticaria in Australia, 1993-1994 to 2004-2005. J Allergy Clin Immunol 2007; 120:878-84.
3. Grimshaw KE, Allen K, Edwards CA et al. Infant feeding and allergy prevention: a review of current knowledge and recommendations. A EuroPrevall state of the art paper. Allergy 2009; 64:1407-16.
4. Koplin JJ, Osborne NJ, Wake M et al. Can early introduction of egg prevent egg allergy in infants? A population-based study. J Allergy Clin Immunol 2010; 126:807-13.
5. Du Toit G, Katz Y, Sasieni P et al. Early consumption of peanuts in infancy is associated with a low prevalence of peanut allergy. J Allergy Clin Immunol 2008; 122:984-91.
6. Thyagarajan A, Varshney P, Jones SM et al. Peanut oral immunotherapy is not ready for clinical use. J Allergy Clin Immunol 2010; 126:31-2.
7. Ho MHK, Wong WHS, Heine RG, Hosking CS, Hill DJ, Allen KJ. Early clinical predictors of remission of peanut allergy in children. J Allergy Clin Immunol 2008; 121:731-6.
8. Anagnostou K, Clark A, King Y, Islam S, Deighton J, Ewan P. Efficacy and safety of high-dose peanut oral immunotherapy with factors predicting outcome. Clin Exp Allergy 2011; 41: 1273-1281.